Non-arteritic anterior ischaemic optic neuropathy (NAION): management

Evidence-based neurology checklist on non-arteritic anterior ischaemic optic neuropathy (naion): management: Investigations Erythrocyte sedimentation rate (ESR) C-reactive protein (CRP) Platelet count Magnetic resonance imaging (MRI) and angiogram head and orbits: in selected cases Optical…

Investigations

  • Erythrocyte sedimentation rate (ESR)
  • C-reactive protein (CRP)
  • Platelet count
  • Magnetic resonance imaging (MRI) and angiogram head and orbits: in selected cases
  • Optical coherence tomography (OCT): this shows a thick prelaminar tissue

Treatment

Experimental treatments

References

  1. Berry S, Lin WV, Sadaka A, Lee AG. Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management. Eye Brain 2017; 9:23-28.
  2. Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol 2010; 55:47-63.
  3. Beck RW, Hayreh SS. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) 2000; 14:118.
  4. Arnold AC. Aspirin should not be recommended to prevent second eye involvement in patients with nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2020; 40:271-273.
  5. Chen J, Zhu J, Chen L, Hu C, Du Y. Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2019; 98:e17861.

Related checklists

Loading...